Space Force weather satellite deemed ready for forecasts
The Space Force said Thursday its newest weather satellite is now operational and will soon be collecting and sharing key weather data with military planners and operators.
The satellite, built by Ball Aerospace, is part of the Space Force's Weather Satellite Follow-on program, or WSF-M. The spacecraft launched more than a year ago and is a first step toward upgrading the service's military weather constellation, which has been on orbit for 60 years.
Col. Robert Davis, who leads Space Systems Command's sensing portfolio, said in a statement the satellite's on-orbit testing went more smoothly than the service expected.
'The operational acceptance of the WSF-M satellite is a pivotal milestone in the Space Force's focus on transitioning toward a more affordable, scalable and resilient weather satellite constellation,' Davis said.
The Space Force is in the midst of replacing its legacy weather satellite constellation, and WSF-M and its companion program are meant to be a bridge to a future capability. As part of the work, the Space Force is considering a hybrid architecture that would include a mix of smaller, less expensive satellites, commercial systems and government-owned spacecraft.
While the service maps out that approach, its current weather satellite capability – the Defense Meteorological Satellite Program, or DMSP – is operating past its service life and is projected to start running out of fuel next year. DMSP sensors can measure things like moisture in the atmosphere, cloud cover and precipitation.
The Pentagon has been trying for more than 20 years to develop a replacement for DMSP. In the '90s it kicked off the National Polar-Orbiting Operational Environmental Satellite System. The effort was canceled after repeated cost and schedule breaches. Lawmakers canceled a second attempt, the Defense Weather Satellite System, in 2012 due to mismanagement.
The Space Force's current plan for augmenting those sensors while it crafts a long-term strategy is to split the requirements between two programs – WSF-M and the Electro-Optical Weather System, or EWS.
The WSF-M satellites will be able to detect wind speeds and tropical storm intensity and determine snow and soil depth. The EWS satellites will use electro-optical infrared sensors to provide visual imagery of cloud cover and forecasting data to inform military missions.
The Space Force plans to launch a second WSF-M satellite in 2028. It has already launched an EWS cubesat built by Orion Space Systems and plans to fly two more EWS spacecraft built by General Atomics – one this year and a second in 2027.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Merck claims study success with PCSK9 cholesterol pill
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. An experimental cholesterol-lowering pill from Merck & Co. succeeded in a pair of late-stage studies, the company said Monday. In one study, Merck's drug, enlicitide, was tested against a placebo in people already taking statins and who have either an inherited condition that causes high cholesterol or are at risk of atherosclerosis. The second trial evaluated enlicitide against other oral therapies, such as ezetimibe, in people on statins and with abnormally high levels of fats in the blood. Merck didn't provide specifics, but said in both cases enlicitide met all of its study objectives and demonstrated 'statistically significant and clinically meaningful reductions' in LDL-C, or 'bad' cholesterol, without any important differences in the number of adverse events. Details will be presented at a future medical meeting. Company shares climbed 2% in early trading Monday. A decade ago, the Food and Drug Administration approved a pair of injectable treatments that could dramatically lower cholesterol in people with heart disease. The drugs, known as PCSK9 inhibitors for the cholesterol-regulating protein they target, were hailed as medical breakthroughs and billed as multibillion-dollar sellers. Instead, their developers struggled to convince payers and physicians of their worth. Sales totals, until recently, have largely disappointed. Merck believes it will have better luck with enlicitide, which could be the first oral medication that blocks PCSK9. The company has bet heavily on its future, enrolling about 17,000 participants across several late-stage studies. And it's counting on enlicitide to become one of the products that can help it grow sales once the patents protecting Keytruda, its dominant cancer immunotherapy, expire later this decade. Questions about its post-Keytruda future have spurred a 40% share slide over the last year and heightened pressure on its next prospects to succeed. The company, for its part, has spoken boldly about enlicitide's promise. Research chief Dean Li has described it as likely becoming the first of its kind available, the 'most effective' cholesterol-lowering pill medicine on the market, and the foundation for future drug combinations. Enlicitide should also be able to sidestep the reimbursement issues long weighing down sales of PCSK9 blockers, CEO Robert Davis said during a presentation in January. Though the drug is a so-called macrocyclic peptide and thus more complicated to make than traditional small molecule pills, Merck has invested significantly in production and believes it can manufacture enlicitide at a low cost. That could help the company 'price it in a way that won't create the excess challenges' others have had and obtain a 'competitive advantage,' Davis said. Still, there is a large collection of branded and generic cholesterol drugs available, as well as multiple newer medicines in advanced testing. AstraZeneca, for one, has a PCSK9 pill in development that some analysts believe to be a meaningful threat to Merck's program. While there are 'early signs' Merck's drug might be more effective, AstraZeneca's could be 'more tolerable and easier to administer,' Leerink Partners analyst Daina Graybosch wrote in April. The size of enlicitide's effects in Phase 3 testing, then, will be closely scrutinized. In Phase 2 trials, a variety of enlicitide doses lowered LDL levels by up to 60% after eight weeks of treatment. One of the Phase 3 studies Merck reported on Monday tested cholesterol levels after 24 weeks, and there is typically a 'degradation in efficacy' when companies move a drug into larger, longer trials, wrote Jefferies analyst Dennis Ding. Ding also speculated that drug adherence could be lower in Merck's studies, as food intake disrupts enlicitide effectiveness. 'The magnitude of benefit will be key to watch,' he wrote.
Yahoo
19 hours ago
- Yahoo
Scientists investigate little-known side effect of next-gen power plants: 'So important'
In a study from the University of California, Davis published in Nature Water, scientists explained how floating solar projects impact birds and other wildlife, as explained in a summary published on Since 71% of the Earth is covered by water, placing solar panels on bodies of water is becoming a popular way to increase affordable energy projects without displacing land use. However, few studies have been done about how solar panels on water, or floating photovoltaics, affect aquatic wildlife. According to the National Audubon Society, more than 33% of bird populations in the U.S. are at high or moderate conservation concern. "Habitat loss due to agricultural intensification and urbanization is arguably the biggest threat to birds, along with climate change," said Virginia Tech associate professor in the College of Natural Resources and Environment Ashley Dayer in a school press release. "That's why it's so important to understand how waterbirds are going to respond to floating solar and if there is the possibility for conservation concessions at new floating solar facilities," said Elliott Steele, a UC Davis Wild Energy Center postdoctoral scholar who co-authored the study, per the summary. "We want to advance clean energy while promoting healthy, functional environments," Steele continued. "Achieving this balance requires that we rigorously study and understand how wildlife responds to floating solar so we can ensure that negative impacts are avoided and potential ecological benefits are realized." In the study, UC Davis scientists investigated how floating photovoltaic projects could impact birds. They documented a wide diversity of birds and their interactions with floating solar panels, as well as human interactions with wildlife on solar panels, sometimes trying to deter them. "We immediately knew this was a very important interaction, especially given the precipitous decline in waterbird numbers globally," said UC Davis professor Rebecca R. Hernandez in the summary. "We leveraged our team's expertise in ecology and energy system science to identify risks and solution pathways such that waterbirds and floating PV can coexist." "While we're at this critical threshold of renewable energy development, we want to put more thought into the design that can benefit birds and other wildlife as we go forward," said UC Davis Ph.D. candidate Emma Forester, per The scientists concluded that more research needs to be done to further explore how waterbirds interact with floating solar panels, as well as the effects they have on each other. What's the biggest obstacle stopping your organization from using solar panels? They're too expensive Don't know where to start They're an eyesore We already use solar panels Click your choice to see results and speak your mind. According to the summary, the authors have continued studying this in the field, noticing "black-crowned night herons resting on a floating solar structure before dawn, double-breasted cormorants jockeying for a favorable site, black phoebes nesting under panels, and more." Solar panels can help decrease harmful planet-warming pollution from other energy sources, like coal and natural gas, which contribute to loss of habitat for waterbirds. However, solar panels do take up land. According to the National Renewable Energy Laboratory, it would take up to 0.8% of the entire area of the United States to meet our energy needs. With floating solar panels, scientists could create solar systems that don't destroy habitats. Incorporating solar panels onto bodies of water or in farm systems could have added benefits, including water retention and space savings. Fortunately, scientists have noticed positive interaction with water birds and floating solar panels so far. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Bloomberg
a day ago
- Bloomberg
Trump's Golden Dome Creates Opening for Space Force to Gain Relevance
By and Sana Pashankar Save Five years after its formation during President Donald Trump's first administration prompted jokes about the Star Trek-style logo and inspired a Netflix Inc. sitcom with Steve Carell, the US Space Force is still looking for respect. 'Many people don't even understand the Space Force is real,' General Michael Guetlein, the agency's vice chief of space operations, told a Washington area conference in March. 'That was a luxury that we had when space wasn't contested. We no longer enjoy that luxury.'
